UB Paderborn / Katalog / Suche / in CDI

26 – 50 von 635

Sortiert nach

Antifungal susceptibilities of Candida, Cryptococcus neoformans and Aspergillus fumigatus from the Asia and Western Pacific region: data from the SENTRY antifungal surveillance program (2010-2012)

Journal of antibiotics, 2015-09, Vol.68 (9), p.556-561

2015

Volltextzugriff (PDF)

Geographic Distribution and Antifungal Susceptibility of the Newly Described Species Candida orthopsilosis and Candida metapsilosis in Comparison to the Closely Related Species Candida parapsilosis

Journal of Clinical Microbiology, 2008-08, Vol.46 (8), p.2659-2664

2008

Volltextzugriff (PDF)

Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008–2009)

Diagnostic microbiology and infectious disease, 2010-11, Vol.68 (3), p.278-283

2010

Volltextzugriff (PDF)

Trends in the susceptibility of U.S. Acinetobacter baumannii-calcoaceticus species complex and Stenotrophomonas maltophilia isolates to minocycline, 2014-2021

Microbiology spectrum, 2023-12, Vol.11 (6), p.e0198123-e0198123

2023

Volltextzugriff (PDF)

Use of Micafungin as a Surrogate Marker To Predict Susceptibility and Resistance to Caspofungin among 3,764 Clinical Isolates of Candida by Use of CLSI Methods and Interpretive Criteria

Journal of Clinical Microbiology, 2014-01, Vol.52 (1), p.108-114

2014

Volltextzugriff (PDF)

Frequency of fks Mutations among Candida glabrata Isolates from a 10-Year Global Collection of Bloodstream Infection Isolates

Antimicrobial Agents and Chemotherapy, 2014-01, Vol.58 (1), p.577-580

2014

Volltextzugriff (PDF)

Ceftolozane-tazobactam activity against clinical isolates of Pseudomonas aeruginosa from ICU patients with pneumonia: United States, 2015–2018

International journal of infectious diseases, 2021-11, Vol.112, p.321-326

2021

Volltextzugriff (PDF)

Azole resistance in Candida glabrata clinical isolates from global surveillance is associated with efflux overexpression

Journal of global antimicrobial resistance., 2022-06, Vol.29, p.371-377

2022

Volltextzugriff (PDF)

Antifungal Susceptibilities of Candida Species Causing Vulvovaginitis and Epidemiology of Recurrent Cases

Journal of Clinical Microbiology, 2005-05, Vol.43 (5), p.2155-2162

2005

Volltextzugriff (PDF)

Activities of E1210 and Comparator Agents Tested by CLSI and EUCAST Broth Microdilution Methods against Fusarium and Scedosporium Species Identified Using Molecular Methods

Antimicrobial Agents and Chemotherapy, 2012-01, Vol.56 (1), p.352-357

2012

Volltextzugriff (PDF)

Antifungal Activity of Isavuconazole and Comparator Agents against Contemporaneous Mucorales Isolates from USA, Europe, and Asia-Pacific

Journal of fungi (Basel), 2023-02, Vol.9 (2), p.241

2023

Volltextzugriff (PDF)

Triazole and Echinocandin MIC Distributions with Epidemiological Cutoff Values for Differentiation of Wild-Type Strains from Non-Wild-Type Strains of Six Uncommon Species of Candida

Journal of Clinical Microbiology, 2011-11, Vol.49 (11), p.3800-3804

2011

Volltextzugriff (PDF)

Echinocandin and triazole antifungal susceptibility profiles for Candida spp., Cryptococcus neoformans , and Aspergillus fumigatus : application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY Antimicrobial Surveillance Program (2009)

Diagnostic microbiology and infectious disease, 2011, Vol.69 (1), p.45-50

2011

Volltextzugriff (PDF)

Ceftolozane-tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in Latin America: report from an antimicrobial surveillance program (2013–2015)

The Brazilian journal of infectious diseases, 2017-11, Vol.21 (6), p.627-637

2017

Volltextzugriff (PDF)

Low Prevalence of fks1 Hot Spot 1 Mutations in a Worldwide Collection of Candida Strains

Antimicrobial Agents and Chemotherapy, 2010-06, Vol.54 (6), p.2655-2659

2010

Volltextzugriff (PDF)

Caspofungin Etest Susceptibility Testing of Candida Species: Risk of Misclassification of Susceptible Isolates of C. glabrata and C. krusei when Adopting the Revised CLSI Caspofungin Breakpoints

Antimicrobial Agents and Chemotherapy, 2012-07, Vol.56 (7), p.3965-3968

2012

Volltextzugriff (PDF)

Antimicrobial activity of ceftolozane/tazobactam tested against contemporary (2015–2017) Pseudomonas aeruginosa isolates from a global surveillance programme

Journal of global antimicrobial resistance., 2020-06, Vol.21, p.60-64

2020

Volltextzugriff (PDF)

In Vitro Activity of a Novel Broad-Spectrum Antifungal, E1210, Tested against Aspergillus spp. Determined by CLSI and EUCAST Broth Microdilution Methods

Antimicrobial Agents and Chemotherapy, 2011-11, Vol.55 (11), p.5155-5158

2011

Volltextzugriff (PDF)

Identification of Candida nivariensis and Candida bracarensis in a Large Global Collection of Candida glabrata Isolates: Comparison to the Literature

Journal of Clinical Microbiology, 2009-04, Vol.47 (4), p.1216-1217

2009

Volltextzugriff (PDF)

In Vitro Activity of Isavuconazole and Other Mould-Active Azoles against Aspergillus fumigatus with and without CYP51 Alterations

Journal of fungi (Basel), 2023-05, Vol.9 (6), p.608

2023

Volltextzugriff (PDF)

Lodderomyces elongisporus Masquerading as Candida parapsilosis as a Cause of Bloodstream Infections

Journal of Clinical Microbiology, 2008-01, Vol.46 (1), p.374-376

2008

Volltextzugriff (PDF)

Update on the activity of delafloxacin against acute bacterial skin and skin-structure infection isolates from European hospitals (2014–2019)

Journal of global antimicrobial resistance., 2020-12, Vol.23, p.278-283

2020

Volltextzugriff (PDF)

Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe: Report from the SENTRY Antimicrobial Surveillance Program, 2016 to 2018

Antimicrobial agents and chemotherapy, 2020-04, Vol.64 (5)

2020

Volltextzugriff (PDF)

Antifungal Susceptibility Testing: Practical Aspects and Current Challenges

Clinical Microbiology Reviews, 2001-10, Vol.14 (4), p.643-658

2001

Volltextzugriff (PDF)

Antifungal susceptibility patterns of a global collection of fungal isolates: results of the SENTRY Antifungal Surveillance Program (2013)

Diagnostic microbiology and infectious disease, 2016-06, Vol.85 (2), p.200-204

2016

Volltextzugriff (PDF)

26 – 50 von 635

Suche als RSS-Feed

Aktive Filter

KollektionOxford Journals 2020 Medicine

KollektioneBooks on EBSCOhost

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(616)
Mit Volltextzugriff
(566)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(483)
Life Sciences & Biomedicine
(464)
Humans
(348)
Microbiology
(326)
Biological And Medical Sciences
(284)
Infectious Diseases
(251)
Medical Sciences
(220)
Microbial Sensitivity Tests
(182)
Fundamental And Applied Biological Sciences. Psychology
(130)
Pharmacology. Drug Treatments
(128)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(123)
Antifungal Agents - Pharmacology
(120)
Pharmacology & Pharmacy
(102)
Anti-Bacterial Agents - Pharmacology
(83)
Mycology
(81)
Candida - Drug Effects
(79)
Antifungal Agents
(72)
Candida
(71)
Antibacterial Agents
(67)
Female
(62)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Antifungal susceptibilities of Candida, Cryptococcus neoformans and Aspergillus fumigatus from the Asia and Western Pacific region: data from the SENTRY antifungal surveillance program (2010-2012)

Geographic Distribution and Antifungal Susceptibility of the Newly Described Species Candida orthopsilosis and Candida metapsilosis in Comparison to the Closely Related Species Candida parapsilosis

Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008–2009)

Trends in the susceptibility of U.S. Acinetobacter baumannii-calcoaceticus species complex and Stenotrophomonas maltophilia isolates to minocycline, 2014-2021

Use of Micafungin as a Surrogate Marker To Predict Susceptibility and Resistance to Caspofungin among 3,764 Clinical Isolates of Candida by Use of CLSI Methods and Interpretive Criteria

Frequency of fks Mutations among Candida glabrata Isolates from a 10-Year Global Collection of Bloodstream Infection Isolates

Ceftolozane-tazobactam activity against clinical isolates of Pseudomonas aeruginosa from ICU patients with pneumonia: United States, 2015–2018

Azole resistance in Candida glabrata clinical isolates from global surveillance is associated with efflux overexpression

Antifungal Susceptibilities of Candida Species Causing Vulvovaginitis and Epidemiology of Recurrent Cases

Activities of E1210 and Comparator Agents Tested by CLSI and EUCAST Broth Microdilution Methods against Fusarium and Scedosporium Species Identified Using Molecular Methods

Antifungal Activity of Isavuconazole and Comparator Agents against Contemporaneous Mucorales Isolates from USA, Europe, and Asia-Pacific

Triazole and Echinocandin MIC Distributions with Epidemiological Cutoff Values for Differentiation of Wild-Type Strains from Non-Wild-Type Strains of Six Uncommon Species of Candida

Echinocandin and triazole antifungal susceptibility profiles for Candida spp., Cryptococcus neoformans , and Aspergillus fumigatus : application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY Antimicrobial Surveillance Program (2009)

Ceftolozane-tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in Latin America: report from an antimicrobial surveillance program (2013–2015)

Low Prevalence of fks1 Hot Spot 1 Mutations in a Worldwide Collection of Candida Strains

Caspofungin Etest Susceptibility Testing of Candida Species: Risk of Misclassification of Susceptible Isolates of C. glabrata and C. krusei when Adopting the Revised CLSI Caspofungin Breakpoints

Antimicrobial activity of ceftolozane/tazobactam tested against contemporary (2015–2017) Pseudomonas aeruginosa isolates from a global surveillance programme

In Vitro Activity of a Novel Broad-Spectrum Antifungal, E1210, Tested against Aspergillus spp. Determined by CLSI and EUCAST Broth Microdilution Methods

Identification of Candida nivariensis and Candida bracarensis in a Large Global Collection of Candida glabrata Isolates: Comparison to the Literature

In Vitro Activity of Isavuconazole and Other Mould-Active Azoles against Aspergillus fumigatus with and without CYP51 Alterations

Lodderomyces elongisporus Masquerading as Candida parapsilosis as a Cause of Bloodstream Infections

Update on the activity of delafloxacin against acute bacterial skin and skin-structure infection isolates from European hospitals (2014–2019)

Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe: Report from the SENTRY Antimicrobial Surveillance Program, 2016 to 2018

Antifungal Susceptibility Testing: Practical Aspects and Current Challenges

Antifungal susceptibility patterns of a global collection of fungal isolates: results of the SENTRY Antifungal Surveillance Program (2013)

Aktive Filter

Suchergebnisse filtern